Primary Chemoprevention of Familial Adenomatous Polyposis With Berberine Hydrochloride
Status:
Unknown status
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
In recent years, Berberine hydrochloride has been reported to inhibit cancer cell
proliferation and to be cytotoxic towards cancer cells. Patients with familial adenomatous
polyposis have a nearly 100 percent risk of colorectal cancer. The aim of this study is to
investigate the chemopreventive effects Berberine hydrochlorid on the regression of
colorectal adenomas.